Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I got the rest of my order filled @ about 9:00 Pacific time.
That's cool. I appreciate the advice. I was thinking about the all or none order, but decided against it because the security is so thinly traded it may not ever get filled in one transaction. I chose to purchase at .65 because I figured that was the floor. It seems to be the case so far. Though the market maker would lead you to believe the floor has been .58 in the last week or two, that was only a few shares that MM bought, not what the average investor could have bought at. It is possible it could dip to .60 - or even .55. If that proves to be the case, it will be there for only a short while. .65 is a bargain, especially for the amount I'm trying to buy. I just need another day like last Monday!
Just curious about why you'd do that. How many did you offer?
OUTRAGEOUS, I only had 150 shares execute out of my remaining 35,684 partially filled order @ .65. I paid $10 for that BS!!!
I wish I was able to increase my position @ .65, but the market maker keeps passing me by. I suppose they want share!!!
I have the same partially filled standing order @ .65 as I had last Monday!
You merely state the obvious, based on a whole lot of "ifs"!!! Anybody can play devil's advocate, living in the land of hypotheticals!
If I won the lottery next week and chose to receive the payment in one lump sum, Uncle Sam would eat me up in taxes. I should take the 26 payments, see, because that would ease the tax burden. Maybe I should open a LLC, then, maybe I could create a tax shelter, ... .
The point is, we should focus on what is most probable. Abbott obviously sees promise or they would not have licensed it. I propose that Abbott not only believes in the technology, but has already invested more than a few million dollars in developing Recaf, and they have not returned the license. Abbott is under no pressure to make any anouncement regarding Recaf development and it is in there best interest to hold off on such an announcement until they are ready to go to the FDA for trials, because of the pending milestone payment that would be triggered by making any such an announcement, which would be in the milions.
The bottom line is, I am willing to take the risk because I like the odds. You don't, and are not willing to take the risks. I am not encouraging anybody to do anything. My investment speaks for itself. I am long on this, period. So, let's wait for the outcome, compare notes, and then dicuss the should'ves, could'ves and the would'ves. I hope your conservative investment practices correspond nicely with your situation. If I was 60+ I'd be conservative as well, but I am much younger, have different cicumstances and enough time to recover from mistakes before I reach my 60's.
I agree with everything you stated. Even if, Abbott was unsuccessful in incorporating the Recaf into their Architect system, I'm confident that Recaf would hit the market as a stand alone blood serum test. The technology holds too much promise to just be ignored. It's just a matter of time, and at 39 I have plenty of it, at least I hope so!
Not sure whether or not they were tissue test, and no that information was not published.
Reverse is now blocked! Oh what a relief!!!
Thanks for that infomation!!!
Fluffy, Reverse is a bonafide basher. You can post a pr from Abbott and he will still demonstrate his idiocracy. You can't argue a point with this character because his arguments aren't based in logic. He has been exposed for the rest of the board to see and thereby lost all of the credibility that he never had.
I say that we just leave him to wallow in his own dribble by not responding to him.
Again, Goldseeker, I apologize for putting you in the same class as this clown!
Where's that ignore button?
Okay Gold Seeker, sorry for not recognizing your contributions to the board. I suppose my statement holds true for Reverse, though!
By the way, the 1st 2 blind tests were for prostate and the third was for breast cancer. The breast had the best results, but the 1st two were equally impressive. They kept sending more test because the results were so astounding. They couldn't believe it at first!
Ah, now I get it. You are retired with a lot of time on your hands. Posting on message boards to share your abundant wisdom must be a hobby of yours.
Well, FYI, I happen to know that Abbott did not rush into this agreement without doing extensive due dilligence, which included blind studies (3 of them), of which Biocurex could not have possibly manipulated. They also knew there was a better than 50% chance they would not return the license. How many examples can you give of Abbott returning a license.
I respect you as an older gentleman, but I don't think you and I have anything more to discuss. However, I will be more than happy to accept a congratulations from you pending the outcome of this investment!
I truly do wish you the best and hope you jump aboard during one of the run-ups before the price is out of your reach!
Erthang
Now that you mention it, "mysscat" you are completely right. Unfortunately, for the board, I believe they are like flies around dung, though they know they are antagonistic and unwanted, we can't get rid of them. I suppose the best we can hope for is to ignore them and not give them a platform to speak on! Is there an ignore feature on this board? I'd like to block Gold seeker and Reverse. They have not posted one useful message since they have been here. What a waste of board space!!! They probably don't own any shares, either. What kind of a person would spend hours posting and checking a board when they have no vested interest? Let me guess, someone with no life! A social misfit or geek! A paid basher?
A normal, mentally healthy person that led an enriched life certainly would not be hanging around here, with nothing to gain or lose from this investment! We are dealing with a pair of misfits, folks!
"There is no outside verification that the tecnology works."
That is completely false. You think Abbott signed a licensing agreement without verifiying that the technology works? Pleazeeee!!!
You just want to see a published study so that the stock price will immediately reflect that fact. Personally, I am not looking for short term gains. I am long, and is why my money will be long once the technology is approved by the FDA and selling on the market!
You are probably a small player looking to make small gains, day trading this. You probably can't conceptualize making the millions of dollars I am looking to make, and that's okay. The world has room for everyone, lower class, middle class and upperclass. Get in where you fit in!!!
Hypothetically speaking. If you had recaf technology that did everything Biocurex said it would, would you take 8 million up front with 5% royalty on revenues, or 200K along with 15% royalties.
Keep in mind that this is Biocurex's first licensee. It was important for Biocurex to land Abbott, which gives the recaf major credibility. Now, consider this, Biocurex makes a major concession by accepting only 200K in exchange for a fairly high royalty percentage. That would be very enticing for Abbott, given the promise the technology demonstrated during their due dilligence, while accomplishing Biocurex's goal of announcing a major licensing deal with the world's largest cancer diagnostic pharma, backing and developing the technology. Biocurex knew they had to give up some "ass", given they are a tiny start up company signing a behemoth like Abbott.
Biocurex is in the driver's seat regarding exclusive rights vs. non-exclusive rights! If Abbott wanted to get their hands on the technology, they would have to play ball, or watch the tech get developed by another pharma. You are naive if you can't see how not giving Abbott exclusive rights will create competition and a sense of urgency in getting this technology to market. Abbott probably would not have sat on the technology, but can you blame Biocurex for ensuring that, that will not be the case? The sooner a recaf product hits the market, the sooner the company will start realizing revenues!
Like I said, whatever dude!!! There's another 3 bucks in your pocket! I think you've made enough money for one day, so i bid you a good nite!
Gold seeker- Call me selfish, but I can care less if you get back into this stock! Take a chance or not! You can never eliminate the risk factor from a stock investment. You are one of the ones that have been down on this stock and now you want me to affirm your consideration about re-investing, by disclosing my due dilligence? I don't think so! You certainly sounded to me like you knew it all and moved on to greener pastures, judging from your earlier posts! Yet you still linger around here! Why is that?
And it's not necessary for me to post any information that will influence this stock price. If Biocures has what they say they have, and what Abbott believes they have, this thing will touch $80.00 per share, overnight!!! Are you kidding me???
I am saying that, that period of time would have given Goshen, Abbott and Biocurex ample time to improve, progress and integrate the technology. We should see many positive press releases, and maybe even some independent studies regarding the recaf technology, during this time, not the least of which being the December 2007 payment!
There is only one idiot posting on this board and his name is not "erthang". I'm not admitting anything. I didn't state who said what! So any insider information that you speak of is nothing more than you assuming, who said what!!! I could be referring to a stock broker who heard whispers of what likely will be coming around the corner for all you know.
The vibe that I'm getting from reading your posts are that you are a loser, and my hunches tend to be better than 50%.
So, I have responded to you like, 3 or 4 times? So you made, what, all of about $20.
I'm not impressed!
I beg to difer on your assessment of the Abbott licensing deal. Dr. Moro agreed to the small upfront in order to receive a much higher percentage of the revenue once the recaf based test begins to sell! The upfront money had nothing to do with Abbott not getting exclusive rights. Abbott agreed to the much higher percentage because of Biocurex's show of faith in their technology, accepting only 200K, upfront. Also, Abbott was amazed at the potential this technology demonstrated during it's due dilligence phase. If and when the details of the agreement become public, or deciphered through the eventual quarterly reports, you'll see what I mean!
Now, one of Biocurex's intentions for granting non-exclusive rights, as opposed to exclusive rights to Abbott, is to set a fire, ensuring that Abbott will not become complacent with this technology, creating a competitive atmosphere in getting this thing to market! It will work out to be advantageous for all of those that are long on this stock!Biocurex understands that in the long run, due to demand and sales, this arrangement will be substantially more profitable.
Your "reverse" psychology is so evident and remedial it's comical, and probably indicative of your intellectual capacity.
I am more than content to allow you to believe what you will, to suspect what you suspect, and to leave you to your bliss or misery, which ever the case. And as I said, we will revisit the subject when the chips have all fallen.
I look forward to reading more comedy from you, when you accuse me of lying about holding a few hundred thousand shares of this stock as the stock price exceeds $10 per share!!!
"You have made the specific statement that BOCX has received other offers, please tell all who they were from and where we can find that information so that we may review it."
I will not post anything for you to reveiw, for 3 reasons:1),you are consistently negative on this stock, stating your opinions as fact. 2), my source is an insider and told me in confidence. 3), since you are so negatively opinionated, I think you should invest your time, energy and interest into doing some due dilligence of your own.
I am heavily invested for a reason. Part of the reason I am confident in this investment, is because of what I have discovered from my due dilligence. This investment is a lot less risky than most people might want to believe, as you would discover if you invested more due dilligence. Also, I could care less about encouraging someone that is primarily resigned to focusing on every "perceived" negative point they could find to argue against this investment! I much rather sit back, allow you to hold on to your beliefs and doubts, letting the chips fall where they may. Either I will be appear as an idiot, or a genius.
(Also, I suspect you are a paid basher, in which case, you will never concede to the prospects of this being an investment opportunity because you are be paid to do the opposite!)
I will say this though, my due dilligence involved taking the time to build and establish relationships with people who are actively involved with the development of the technology. This does not include just taking management's word for everything, but discovering facts to support it. This has cost me a lot of time and energy, and I am not willing to just pass it on to a skeptic like you.
I consider myself far from an idiot, as evidence by me even having the resources to take advantage of this, "my perceived" investment opportunity! There is a very good reason I am so heavily invested in this company. My advice to you is to reserve your "public judgement" about this investment, until at least late next year. Then you will see whether or not you, and those like minded, missed a great opportunity, or be able to gloat your "I told you so's"!.
Well Reverse, any investment is a risk. I have done some due dilligence. One fact I will tell you is that Biocurex has received more offers (plural), but Biocurex turned them down because they were not as attractive as the Abbott deal. The reason for the small initial payment is because the deal is back loaded with the milestone payment and a fairly large percentage of the revenue from sales, comparatively speaking. By the way, that demonstrates the enormous faith and belief Biocurex has in the technology making it to market!
I am not losing any sleep and very confident in my decision to heavily invest in Biocurex. My job is not to convince you or anyone else, however, when it's all said and done I believe some will view me as somewhat of a guru, or one who somehow had the balls and the resources to see and take advantage of an opportunity in a highly speculative stock. Regardless, I believe the end result will translate into tremendous wealth.
Wish me luck if you believe that is what I will need. I don't believe that to be the case though, I think you will see that when it's all said and done, and you will understand it was insight and not luck that was responsible for my good fortune!
Peace!!!
True. At the time of my interview with Dr. Moro, I had about 130K @ an avg 1.19. At present I'm at 1.03, 185K. When the rest of my order executes I'll be @ .97, 220K.
There must be a number of buyers waiting to buy @ .65. This experience, watching a bid of .60, when I'm trying to buy @ .65,has definitely taught me a few things about how the market maker creates the market!
True. At the time of my interview with Dr. Moro, I had about 130K @ an avg 1.19. At present I'm at 1.03, 185K. When the rest of my order executes I'll be @ .97, 220K.
There must be a number of buyers waiting to buy @ .65. This experience, watching a bid of .60, when I'm trying to buy @ .65,has definitely taught me a few things about how the market maker creates the market!
The showing bid is not accurate because I still have a standing order to buy 35K, since Monday, yet the showing bid is .60. I think the market maker is trying to coax the price down so he could buy shares at a discount and sell them back to the market @ a higher price. The good news is that no one is selling at .65 or I would be filled by now. I suppose my partially filled order (33,500 @ .65 on Monday)was a great buy!
It's already up!
Gold seeker - You have it wrong and are bordering on nonsense.
"You are totally out of line. It has been a year and a half since the licensing and we should have heard something by now."
Who are you referring to when you use the word "we". When reading your post in context it appears that you are referring to shareholders. There is a confidentiality agreement in place with the license. Biocurex has heard something (a lot) from Abbott and there is progress being made. If that wasn't the case the license would have been returned by now. It is evident the technology is showing a lot of promise. In additon, Abbott is holding off on announcing anything that would trigger that milestone payment for obvious reasons. So "we" the shareholders won't hear anything until the milestone payment is triggered. Maybe Bocxman has an extra "dunce" hat for you too!
"You obviously don't know it but you're whole basis of fact is relying on what management says. ABT is only making a study to see if the technology works and they don't know yet after all this time."
Reverse you don't know what you are talking about. Common sense should tell you that Abbott has already confirmed the tech works. They are working toward integrating it into their architect system, then towards FDA approval for their system. You're saying that a company as large, dominant in the field of cancer diagnostics, with the resources and know how as Abbott, after more than a year and a half of working and learning the ins and outs of recaf, along with the option of returning the licensing agreement at any time, does not know whether or not the technology works! SHUT UP!!! You deserved to be slapped, or be wearing a dunce cap, as Bocxman would say!
"(1) That when a stock trades at a 20% spread between the bid and ask- it is not a positive thing." "2) When a stock has the biggest volume day in a month and it is all trades at the bid- It is not a positve thing."
The stock was not actually trading at a 20% spread. That was the market maker somehow picking up 500 shares @ .58 when the actual bid was .65. I know because I had a buy order in since last week @ .65 for 69K of which only 31K filled yesterday. This is a great buying opportunity, so for me it is a great thing. If you have common sense and been following this stock for any length of time you would know that the price dips during periods of no news. Abbott is taking their time and holding off on the time they will be obligated to make the milestone payment because they can and it makes good business sense. Things are going well with their development of the technology or else they would have returned the licensing agreement. They have received offers to license the technology from other pharmas, but Biocurex has declined because they will not accept any offers less than the agreement they have with Abbott, which tells me that they have a wonderful arrangement.
"(3)When the only thing going for a stock is a technology claim by management which after years is still unproven- it is not a positive thing."
The technology is proven to Abbott (The leader in diagnostic cancer tests) and that is the most important thing here because they licensed the technology after extensive due dilligence. Read my interview with Dr. Moro again, regarding the three rounds of blind tests.
So you cite "so called facts" and you really don't know what the hell you are talking about! So my advice is for you to stop posting false and misleading messages. Better yet stop posting all together until you do some due dilligence yourself, get an education and understand the difference between fact and opinion. Example: The fact is, you are ignorant and consistently are showing you do not know what you are talking about!
Stock jock, I can guarantee you they are not selling at these levels. Just because they registered to sell doesn't suggest the price in which they will sell at. It just opens the door for them to sell when the time is right! Perhaps they are anticipating an announcement shortly that will rocket the pps through the roof and are preparing themselves to sell part of their position into the run-up! That seems a likely scenario.
It's krazy how some of you tend towards the negative scenarios, when positive scenarios seem to be much more plausible. If you are not optimistic on the stock, why are you here and invested in it? I view negative people and pitiful, victimized whinners in the same light. Not saying that's what you are, just sharing an opinion on consistently negative people.
Thanks Half full. I feel like I'd deserve it with all of my faith, patience and perserverence!
There you go reverse, true to form with the negative spin you try to read into everything. You sound ridiculous, and I doubt anyone believes any of your hairbrained doomsday theories!
I have an open order to buy 69K shares @ .65 that was partially filled with 35,600 remaining. It's krazy because the low was .58 today, and I had my order in since last week. My broker told me that there was only one order filled @ .58 for 500 shares and it was the market maker that made the purchase so that they could resell it on the open market for a small profit!
I like Bocxman too, but to make a request that he posts once a day seems a little much. A strange request. Just my opinion!
You sound very insecure and needy!
I re-read the interview I had with Dr. Moro back in March, or was it Feb. I was encouraged by the following statement:
From this date, how long do you think it will take before we see a Recaf product from Abbott?
(Dr. Moro)I can't tell you. I have an idea, but Abbott has muffled me. I can't say because of the regulations.
Are we close?
(Dr. Moro)We are getting closer. That's for sure.
This dialogue tells me that things are going very well over at Abbott developing and incorporating the technology. He has a idea of about when Abbott will be ready to market the recaf product.
"We are getting closer. That's for sure.", implies that they are making progress. It is only a matter of time. Imagine the press and coverage this product will get once it goes public. Hopefully it will be a very bullish atmosphere on wall street during this time.
For those of you who haven't read the interview, here it is in it's entirety, including the quote, unquote, confidential parts that were omitted in the original post.
I had the interview with Dr. Moro today. It went very well. He was very candid and we built a repoire within a short time on the phone. I wanted to thank "Kag" for suggesting the tape recorder. He (Dr. Moro), has a somewhat heavy french canadian accent and I had to play what he said back a few times in some cases to clearly understand what he said. It is the only way I would have been able to accurately transcribe the questions and answers. I am not at liberty to discuss certain things that we discussed because at certain junctures, he asked me to keep it "in confidence", however, things are looking very good and he answered all of the core questions I asked and then some.
How did the Philadelphia meeting go?
(Dr. Moro)It went very well.
I was wondering how things are going @ Goshen ?
(Dr. Moro)"We had to cleave the antibodies that we have. It's only been about a week or two ago that we have been able to do it consistently. It is an IDM antibody, not an ITG antibody, which is a lot trickier to work with. It has taken us the better part of 6 months to figure out how to get the antibody where we want. Our goal with Goshen , is imaging. In order to image the tumors, you want to put the smallest molecule possible in the other person. We are going to be putting antibodies into a person and we don't want them to have an immune reaction. The way to do that is to take all of the excess weight out of the antibody away; and the way to do that is to cleave the antibodies with the enzymes, you now have a much smaller piece. We have been able to reduce it from 950,000 to 140,000 and we can now cleave that into half of the basic parts. As a matter of fact, we are going to now start the animal studies (testing in mice) that they are going to need before they take this to the next level, which is testing in humans.. By the end of the year, I anticipate it would be proven that recaf is useful in the process of imaging tumors. You know what, it either works or it doesn't. Other issues can be worked out at a later stage, but the bulk idea of it working or not, should be proved by the end of the year.
Once it's proven that it works, would we license it out to other companies to develop like we did with Abbott?
(Dr. Moro)That's the idea. The only thing I would like to keep for ourselves, is some therapy applications. because at some point and time we start collecting money from royalties, I want to grow us a company, revenue wise. We want to keep something for ourselves. So right now, that is our concern because we have work here for the next 5 to 10 years. We want to plan for the future, manufacture and sell products using aspects of the technology, exclusively, but we are really very, very far away from that at this point. What we want to do is to develop licensing relationships and then move on to a new application
From this date, how long do you think it will take before we see a Recaf product from Abbott?
(Dr. Moro)I can't tell you. I have an idea, but Abbott has muffled me. I can't say because of the regulations.
Are we close?
(Dr. Moro)We are getting closer. That's for sure.
Do you believe the Recaf serum test by Abbott will likely need Pre Market Approval from the FDA?
(Dr. Moro)I don't know. I'll tell you why I don't know. I was talking to these other big guys and I talked to a big company on Tuesday, they came over here. They sell about 16 million PSA tests a year. Some of them think they can get away with a 510K and some think they will need Pre Market Approval.
Do you think these companies that want to license this technology want to combine it with the PSA test?
(Dr. Moro)In some cases, I imagine that would be the case. They are not telling me, but I can smell it. With the Recaf and the PSA, you don't have an overlapping of the correlations, so when you don't have an overlapping correlation of values you get a better result. As a matter of fact, I am working on a patent for the combination. And on the other hand, the fact that you already have a big market for PSA, somebody's going to say,why not put the two together. Now, how are they going to do it, what price are they going to have, I don't know. That one they are keeping very close to their chest.
PSA is good for localizing prostate cancer, but I'm thinking the Recaf technology would locate many other types of cancer.
(Dr. Moro)That's true, but on the other side of the coin, if you want to go to the FDA, and say I have a tumor finding system, the FDA is going to say prove it. They'll want all of the data and samples to run through there own independent system for all of the different kinds of cancers. And that becomes a very, very taxing task, because now they have to do 100 - 200 breasts, 100 - 200 lungs, etc ... . That would take too long. So there is a much easier way to do it. I just want the approval for prostate, and while we get that, we give them the evidence for lung and then I apply for an extension of the application now for lung, and so on and so forth. And so we'll be selling by the time they go for the second one and the third one. It's faster and less expensive, money wise. It will be the same amount of money, but at least we don't have to put it all together.
Given that Recaf can detect lung cancer @ such a high level of specificity, you would think everybody would want a piece of this, especially since the only other way to accurately confirm lung cancer is to do a lung biopsy.
(Dr. Moro)That's right! Well, lung is a tough case. You don't know until you put a brochoscope inside and that's really invasive, and in some cases you can't reach it either. If you have an image of some sort and you have an elevated Recaf, then you can basically say that the person has the cancer.
How much longer do you think we will be on the pinks?
(Dr. Moro)That's a very intriguing question because we have also been moving very swiftly in that area. We have answered questions, they have come back with more questions, we have answered those questions, so we have this back and forth with the NAZ, so it looks very good now, but I don't know what's in the future for us, because I've been burned so many times already. One thing I can tell you for sure is this, no matter how many times they say no, we are going back. Eventually, at some point, they are going to run out of questions. We now have a broker / dealer that seems to be working very well with us. We have to wait and see how everything pans out. We have a number of things that are brewing, we are working on some financing, in terms of the work in the lab. It's a funny business, because we have a lot of people working on products and on different deals. What's happening now, basically is a lull period where we really have nothing to say. So we have had no press releases because we have nothing to say. What happens is, you are creating a pressure, a thrist for things to happen. So then what happens is, all of a sudden now you have ten things happening at once, which is no good either because I would prefer to spread the news over a period of time. People exaggerate if you put too much out. But if it happens it happens. You can not control them.
What it's going to take to get the stock to move is the announcement of more licensing deals?
(Dr. Moro)You know, I am surprised at two things. The first is at how stable we have been, trading between .70 - .80. The second is, when we put out a press release or two, we get about a .20 swing, with very little significant news. It's kind of awkward because we have about 4,000 share holders, you would imagine, in order to move that number of shareholders, you would think it would take something bigger than that, but it doesn't. I am glad it works like that because otherwise it would be an insurmountable task. Answer me this. You trade in stocks, I don't. I am a science guy. How do you explain this, we sign a deal with the number one diagnostic company in the world, then the stock goes to $2.30, then the works starts to get done. Every week that goes by, we are closer to the finish line. But yet and still we wind up down to .70. I can't make heads or tails of that, can you?
Yeah, it's because we are trading on the pink sheets. People view stocks trading on the pinks as extremely high risk!!!
(Dr. Moro)Well, we'll see what happens when we go off the pinks. Personally, I think we will get a little bump when we go to the OTC, nothing significant. We are working on and close to getting financing for millions of dollars (we are talking to a number of people about that), then getting to the AMEX. After we get into the AMEX, by raising about 4 million dollars. I'm close to getting revenue from Abbott for royalties. It holds me back a little bit in terms of, why increase the share base of the company when we can get our money from Abbott? But I need to move to AMEX, or the Nasdaq (small cap), we can get out even from the bulletin board. At that time we are going to have a very, very different credibility and access to additional money that there is no way we have access to so far.
We are not going to be able to get off the OTC until we begin to get those royalties from Abbott, right?
(Dr. Moro)Well, I can do it through financing because what you basically need is to have 4 million dollars in assets. If you do that, it doesn't matter which way it comes, we get the money from Abbott, we get the money from the market, it's okay. The question is, why dilute the shareholders, if you are going to get it in a short period of time from Abbott. I rather stay on the bulletin board for another year. There are other things, for example: There are many other sides of the technology I want to develop and the patents are not for an indefinite time frame. They expire. You see, so by not exploiting the use of the special patents, we are also losing value. It's a delicate balance. (He asked me to keep this part of the interview confidential) We got a situation with a company where they wanted to do it. They wanted to sign, but they wanted too much. In other words, they didn’t want to pay the royalties that we want. If we were able to convince Abbott to pay a certain amount of royalties, and these guys are much smaller than Abbott, then they should be able to pay it too! So we said, you know what, then, we rather not license it to you, because we only have a limited number of licenses to issue. I’m not willing to waste it on a company not willing to pay what we really need.
(Dr. Moro)How we get value for the company is not a matter of licensees, or the next press release, but it's a matter of where the company is going to be in the next ten years, that's the press release. You have to consider both things.
The patents will expire within the next 10 years, right?
(Dr. Moro)That's not a major consideration because as I told you before, we are writing new ones, which are extensions of what we have. For example, we have ways of preparing and purifying Recaf, every thing we do now will be included in the patents. The licensees would have to keep on paying us with the extensions of the patents.
Well it sounds good!
(Dr. Moro)It does, you know(-),I find myself, sometimes, thinking to myself, I should be jumping up and down, but I'm not. The reason that I'm not is that we get samples from different sources all of the time, and the wave lengthens and we get some interesting results. For example, we get a result that is 85% good, which is down from 92% and 95%, and I get depressed. And I think to myself, what am I getting depressed about? The Recaf works in an unbelieveable way, there is nothing out there that picks up 85%, let alone 95%. It's that I get use to it, and then I get more and more critical. People are saying, what's wrong with you, you should be enthused, but you get spoiled after a while.
What pushed Abbot over the edge in signing a licensing deal?
(Dr. Moro) (Again, he asked me to keep this information he is about to share confidential.) They sent the 1st set of blind samples (using prostate cancer) and it went very well. They couldn’t believe it, so they sent a 2nd round, and that went unbelieveably well, too. Then, they sent a third round, but this time they sent breast cancer, and that went even better with the breast cancer, than we did with the prostate cancer.
An offshoot of this particular part of our conversation, he gave me some numbers: Lung cancer 97% sensitivity and 97.5% specificity (out of 22 cancers); breast is 98.7% sensitivity with 97.5% specificity (out of 88 cancers). Sensitivity refers to the number of false positives, versus, actual detection of a cancer, and specificity refers to the identification of the cancer type.
What is helping you to secure the financing? Is it the technology itself?
(Dr. Moro)Yeah!If you go to a pipe or something like that, you really have to pull down your pants. This way, we finance all the money that we need and it's working very well for us. About what price did you buy?
I bought 130,000 shares at an average price of 1.19.
(Dr. Moro)I wouldn't be concerned about your purchase price. We will be over that shortly. We are significantly underpriced, the market is unreasonable for what we have here, that is .78.
Yeah, I was a bit concerned, being that I paid 1.19 for so many shares and seeing it drop to .70.
(Dr. Moro)You have to be patient. Most of the stock is restricted. That will pay off for you.
How many shares are outstanding?
(Dr. Moro)We have about 38 million or something like that.
Are you holding off on putting anymore shares on the market until the price goes up? Because you had a press release not too long ago regarding selling more shares to investors @ 2.50 per share.
(Dr. Moro)What happened was, we put through a registration stock, to go and sell stock directly through the company and if it is registered, it is not restricted and it allows investors to buy it and we can raise more money. When we did it, we did it at $2.50 because the share price at the time was hovering around the $2.00 mark at the time of the Abbott deal. We actually pulled that out because of the reduction in price. I don't really want to finance at these levels. One and two hundred thousand dollars is not a big deal. I don't want to raise millions of dollars at these levels because it would be murder. Having the stock at $2.00 eight or nine months ago, is criminal, to finance at these levels. And I've got money in the bank so, I'm not worried about it. I have to go, I have somebody waiting on me. Call me anytime you need.
I think the trading volume has to do with the fact that there is only one market maker! I wonder what trading will be like after the 30 days expire and other market makers are brought into the fold.